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The role of parathyroid hormone-related protein (PTHrP) in fetal calcium homeostasis
and placental calcium transport was examined in mice homozygous for the deletion of the
PTHrP gene (PTHrP−/− null; NL) compared to PTHrP+/+ (wild-type; WT) and PTHrP+/−
(heterozygous; HZ) littermates. Fetal blood ionized calcium was signiﬁcantly reduced in NL
fetuses compared to WT and HZ groups at 18days of pregnancy (dp) with abolition of the
fetomaternal calcium gradient. In situ placental perfusion of the umbilical circulation at 18dp
wasusedtomeasureunidirectionalclearanceof 45Caacrosstheplacentainmaternofetal(CaKmf)
and fetoplacental (CaKfp) directions; CaKfp was <5% of CaKmf for all genotypes. At 18dp, CaKmf
across perfused placenta and intact placenta (CaKmf(intact)) were similar and concordant with net
calciumaccretionratesinvivo. CaKmf wassigniﬁcantlyraisedinNLfetusescomparedtoWTand
HZ littermates. Calcium accretion was signiﬁcantly elevated in NL fetuses by 19dp. Placental
calbindin-D9K expression in NL fetuses was marginally enhanced (P <0.07) but expression of
TRPV6/ECaC2 and plasma membrane Ca2+-ATPase (PMCA) isoforms 1 and 4 were unaltered.
We conclude that PTHrP is an important regulator of fetal calcium homeostasis with its pre-
dominanteffectbeingonunidirectionalmaternofetaltransfer,probablymediatedbymodifying
placentalcalbindin-D9K expression.Insituperfusionofmouseplacentaisarobustmethodology
for allowing detailed dissection of placental transfer mechanisms in genetically modiﬁed mice.
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Provisionofcalciumtothedevelopingfetusisessentialfor
bonemineralization,which,ifcompromised,mayincrease
the risk of developing osteoporosis later in life (Tobias &
Cooper, 2004). Maximal fetal accretion of calcium occurs
over the last third of pregnancy, and in the rat, as in other
species, the rise in fetal calcium accretion is exponential
over this period (Comar, 1956). Net calcium ﬂux to
the fetus (CaJnet) is the difference between unidirectional
maternofetal (CaJmf) and fetomaternal (CaJfm) calcium
ﬂuxes (Sibley & Boyd, 1988). The rise in CaJnet over
gestation in the rat is a function of increased CaJmf
(Glazier et al. 1992). Considerable data from a variety of
species suggest that CaJmf is an active process, maintaining
hypercalcaemiaofthefetusrelativetoitsmother,afeature
of all species studied (Sibley & Boyd, 1988; Atkinson et al.
2006). CaJfm is thought to be a diffusional process (Husain
et al. 2004).
In common with other calcium transporting epithelia,
calcium transport across the placenta could plausibly
involve three main steps (Belkacemi et al. 2005; Atkinson
et al. 2006): ﬁrstly, diffusion into the trophoblast from
maternal plasma down an electrochemical gradient
through epithelial Ca2+ channels of the transient receptor
potential (TRP) gene family; secondly, transfer across
the trophoblast cytoplasm bound to the calcium binding
protein calbindin-D9K (Glazier et al. 1992); and, thirdly,
active extrusion into the fetal compartment via plasma
membrane Ca2+-ATPase (PMCA) localized to the fetal
facing basal plasma membrane (Fisher et al. 1987; Borke
et al. 1989). Over the last third of gestation, gene and
protein expression for calbindin-D9K increases markedly
in both mouse and rat placenta (Mathieu et al. 1989;
Glazier et al. 1992; Hamilton et al. 2000; An et al. 2004)
whereas rat placental Ca2+-ATPase expression shows only
a2-to3-foldincrease(Glazieretal.1992).Thisincreasein
rat placental calbindin-D9K expression is associated with
a concomitant, stoichiometric increase in unidirectional
maternofetal 45Caclearanceoverthisperiodleadingtothe
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speculation that calbindin-D9K may be rate limiting for
placental calcium transport in this species (Glazier et al.
1992).
One of the fetal factors implicated in the regulation
of placental calcium transport is parathyroid
hormone-related protein (PTHrP), which is produced
by the placenta as well as by other fetal tissues (Tobias &
Cooper, 2004). Although PTHrP was initially discovered
as the humoral factor responsible for hypercalcaemia of
malignancy, it is now known to have broad expression in
a variety of fetal and adult tissues (reviewed in Philbrick
et al. 1996). The versatility of PTHrP in performing
multiple, yet distinct, biological effects through endo-
crine, autocrine, paracrine and intracrine activities arises
from alternative splicing of the PTHrP gene, giving rise
to three initial translation products which then undergo
post-translational processing to generate N-terminal,
mid-region and C-terminal mature peptide fragments.
Consistent with this concept, calcium transfer into
blood used to perfuse the fetal circulation of the in
situ placenta in thyroparathyroidectomised fetal lambs
was increased by the addition of partially puriﬁed
hPTHrP or recombinant PTHrP(1–84), PTHrP(1–108)
and PTHrP(1–141) but not by synthetic PTHrP(1–34)
(Abbas et al. 1989). This stimulation was rapid (within
1h) and was also conferred by hPTHrP(67–86 amide)
and hPTHrP(75–86 amide) fragments (Care et al. 1990)
suggesting that this activity resides in the PTHrP(75–86)
peptidesequenceandthattheN-terminusisnotinvolved.
Bycontrast,infusionofhPTHrP(1–34)orhPTHrP(75–86
amide) into the fetoplacental circulation of intact rat
fetuses had no effect on the placental transport of calcium
(Shaw et al. 1991).
The availability of fetal mice homozygous for deletion
of the PTHrP gene (PTHrP−/− null; NL) (Karaplis et al.
1994) has allowed closer examination of the effect of
fetal PTHrP on placental calcium transport. NL fetuses
exhibitabnormalitiesofendochondralbonedevelopment
with accelerated endochondral ossiﬁcation, yet, despite
broad PTHrP tissue expression in PTHrP+/+ wild-type
(WT)conceptuses,nogrossmorphologicalabnormalities
were apparent in other tissues from NL fetuses (Karaplis
et al. 1994). In NL fetuses, fetal blood ionized Ca2+
concentration is signiﬁcantly reduced resulting in the
abolition of the fetomaternal Ca2+ gradient (Kovacs et al.
1996; Tucci et al. 1996). The ratio of maternofetal transfer
of 45Ca normalized to that of 51Cr-EDTA (used as a
marker of diffusional permeability) was signiﬁcantly
reduced in NL fetuses when compared to WT and
PTHrP+/− heterozygous (HZ) littermates (Kovacs et al.
1996), suggesting dependence of CaJmf on fetal PTHrP.
Reversal of this effect by fetal injection 90min
before of hPTHrP(1–86) and hPTHrP(67–86), but
not of hPTHrP(1–34), supports the concept that
the mid-molecule region of PTHrP is functionally
important in eliciting these acute effects. Curiously,
in the light of these observations, others report a
higher fetal calcium content in NL fetuses compared
to WT littermates (Tucci et al. 1996), suggesting that
CaJnet is increased in the absence of fetal PTHrP. The
explanation for these apparently divergent observations
could be methodological, but may also reﬂect differences
in the relative contribution of CaJmf and/or CaJfm to
CaJnet. A more detailed examination of the role of fetal
PTHrP on transplacental calcium ﬂuxes is required.
To do this, we have developed a method in which the
fetoplacentalcirculationisartiﬁciallyperfusedinsituinthe
mouse(Bondetal.2006a)allowingseparatemeasurement
ofJmf andoffetoplacentalcalciumﬂux(Jfp)asanestimate
of Jfm. This technique provides a powerful tool to explore
the molecular mechanisms involved in the regulation of
unidirectional placental solute ﬂuxes.
Methods
Chemicals
All chemicals were purchased from either Sigma-Aldrich
Co. Ltd (Poole, UK) or VWR International (Lutterworth,
UK) unless otherwise stated.
Animals
Experiments were performed in accordance with the
UK Animals (Scientiﬁc Procedures) Act of 1986. PTHrP
knockout mice generated by the targeted disruption in
embryonic stem cells of exon IV, the major exon encoding
maturemurinePTHrPprotein(Karaplisetal.1994),werea
kindgiftfromProfessorH.Kronenberg(HarvardMedical
School, USA).
Females (8–12weeks old) and males (6weeks to
8months old) heterozygous for the deleted PTHrP gene
were mated and the ﬁrst day of gestation determined by
the discovery of a copulation plug (term, 19–20days). All
animals were provided with nesting material and housed
incagesmaintainedunderaconstant12hlight–darkcycle
at21–23◦Cwithfreeaccesstofood(BeekayRatandMouse
Diet, Bantin & Kingman, Hull, UK) and tap water. At
the end of the experiment, all animals were killed by
Schedule 1 procedure in accordance with the UK Animals
(Scientiﬁc Procedures) Act of 1986.
Fetuses were genotyped using genomic DNA extracted
from fetal tail tips (DNeasy, Qiagen, Crawley, UK)
with primers speciﬁc to gene sequences for PTHrP
(sense, 5 -GCTACTGCATGACAAGGGCAAGTCC-3 ;
antisense, 5 -GAGCCCTGCTGAACACAGTGAACAG-3 )
and neomycin resistance (sense, 5 -GGAGAGGCTAT-
TCGGCTATGAC-3 ; antisense, 5 -CGCATTGCATCA-
GCCATGATGG-3 ).
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Placental calcium transfer studies
Measurement of unidirectional solute transfer across
either the intact or perfused placenta is often expressed
as solute clearance (Meschia et al. 1967), a formulation
without any underlying mechanistic assumptions (Sibley,
1994). In the present investigation, unidirectional
maternofetalclearancewasmeasuredbothacrossperfused
(CaKmf) and intact (CaKmf(intact)) placenta. Unidirectional
fetoplacental clearance (CaKfp) was measured using
perfused placenta. Net ﬂux (CaJnet) was calculated from
calcium accretion rate in vivo. Unidirectional ﬂux can
be calculated as the algebraic product of unidirectional
clearance and respective arterial concentration (Sibley,
1994).
Unidirectional maternofetal clearance of 45Ca (CaKmf)
across the perfused placenta
CaKmf across the perfused placenta of mice at 18days of
pregnancy (dp) was measured as previously described
(Bond et al. 2006a). The dam was anaesthetized with an
intraperitoneal injection of 300μl fentanyl/ﬂuanisone
(Hypnorm: Janssen Pharmaceutica, Belgium) and
midazolam (Phoenix Pharma Ltd, Gloucester, UK)
mixture (1 part fentanyl (0.315mgml−1) and ﬂuanisone
(10mgml−1), 1 part midazolam (5mgml−1), and 2
parts water). Additional doses of anaesthetic were given
intraperitoneally (2–5μl(g dam weight)−1) during the
course of the experiment as required.
CaKmf was calculated (Sibley & Boyd, 1988) as:
CaKmf =
[v] Q
[A] W
(μlmin
−1(gplacenta)
−1) (1)
where [v] is fetal side placental venous efﬂuent radio-
isotopeconcentration(dpmμl−1),Q istheperfusionﬂow
rate (μlmin−1), W is the placental wet weight (g) and
[A] is the maternal plasma radioisotope concentration
(dpmμl−1) taken at the mid-point of the perfusate
collection period by curvilinear interpolation from a
pooled maternal 45Ca disappearance curve (Bond et al.
2006a).
Unidirectional fetoplacental clearance of 45Ca (CaKfp)
using perfused placenta
In these experiments, the dam was similarly prepared on
18dp as detailed previously for the measurement of CaKmf
(Bond et al. 2006a), but the maternal tail vein was not
cannulated. The arteriovenous difference of 45Ca in Krebs
Ringer solution (containing 10nCi 45CaCl2 ml−1) used to
perfusethefetoplacentalcirculationallowedcalculationof
CaKfp, as given in eqn (2):
CaKfp =
[a] − [v] Q
[a] W
(μlmin
−1(gplacenta)
−1) (2)
where [a] is the radioisotope concentration of arterial
inﬂowing perfusate (dpmμl−1).
Inclusion criteria for perfusion experiments
Data were analysed from those experiments where (a)
perfusate efﬂuent recovery was 95% of perfusate inﬂow,
(b) 45CaCl2 stock injectate radioactivity (dpmμl−1)f e l l
within 95% of the mean value for all experiments, and
(c) the radioisotope injection volume was within 10% of
the 50μl injectate volume. Inclusion criteria (b) and (c)
were introduced to ensure that the radioactivity injected
into each mouse was comparable thereby minimizing
variability in the maternal radioisotope disappearance
curve (Bond et al. 2006a).
Unidirectional maternofetal clearance of 45Ca across
the intact placenta (CaKmf(intact))
CaKmf(intact) across the intact, unperfused placenta was
measured on 18dp using an adaptation of the method
of Flexner & Pohl (1941) as previously described (Bond
et al. 2006a).
CaKmf(intact) was calculated as:
CaKmf(intact) =
Nx
W
  x
0 Cm(t)dt
(μlmin
−1(gplacenta)
−1)
(3)
where, Nx is total radiolabel accumulation (dpm) by
the fetus (corrected for the fetal tail tip retained
for genotyping) atxmin after injection of radiolabel
into the maternal vein and
  x
0 Cm(t)dt is the time
integralofradioisotopeconcentrationinmaternalplasma
(dpm·minμl−1)f r o m0t ox min (taken from the
maternal plasma 45Ca disappearance curve; Bond et al.
2006a).
Maternal plasma 45Ca disappearance curve following
injection into the maternal circulation
A maternal plasma 45Ca disappearance curve was
constructed from 78 dams at 18dp and ﬁtted to a
one-phase exponential decay model (r2 >0.8) as pre-
viously described (Bond et al. 2006a).
Net transplacental ﬂux of calcium (CaJnet)
Calcium content of fetal ash was measured at 17, 18 and
19dp by atomic absorption spectrophotometry (Solaar
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S-Series, Thermo Elemental, Unicam Ltd, Cambridge,
MA, USA) as previously described (Husain et al. 1994).
Tail tips were taken for genotyping as described above.
CaJnet over 24h (1440min) between 17 to 18 or 18 to
19dp was calculated as:
Mean fetal calcium content
1440 W
(nmolmin
−1(gplacenta)
−1)
(4)
where W is mean placental wet weight (g) at either 18 or
19dp, respectively.
Maternal whole blood ionized Ca2+ concentration
Terminal blood samples, taken at 18dp from the
carotid artery following decapitation, were analysed for
ionizedCa2+ concentration(Bayer865Analyser,Siemens,
Berkshire, UK).
Placental PTHrP expression
In order to assess the potential for endogenous placental
production of PTHrP by maternal cells within decidua
(Karperien et al. 1996), PTHrP gene and protein
expressionwereexaminedinfetusesfromwithinthesame
litter. Paired fetal genomic DNA and placental cDNA
from each genotype was ampliﬁed using exon IV-speciﬁc
primers (sense, 5 -GTTTCTTCCTCCACCATCTG-3 ;
antisense, 5 -ATCTGCCCTCATCGTCTG-3 ) and
placental PTHrP protein expression was examined by
immunohistochemistry (see below).
Western blotting
Individual placentas harvested at 18dp were homo-
genized in buffer containing 300mm mannitol, 12mm
Hepes (pH7.6) and 1% protease inhibitor cocktail
(Sigma-Aldrich)for30s.Thehomogenatewasretainedor
centrifuged at 2500g for 5min at 4◦C (Sorvall Discovery
100SE, Kendro Laboratory Products, Bishop’s Stortford,
UK).Aliquotsofthispost-nuclearsupernatant(PNS)were
retained and the remaining PNS centrifuged at 100000g
for 30min at 4◦C to obtain the membrane fraction.
Both fractions were analysed for protein concentration
(Bio-Rad Protein Assay) and stored at −80◦C for further
analysis.
Protein–SDScomplexeswerepreparedwith(Settleetal.
2004) or without (Bond et al. 2005) heat denaturation
and SDS-PAGE performed followed by electrotransfer to
nitrocellulosemembranes(GEHealthcare,LittleChalfont,
UK).Theantiserausedwererabbitpolyclonalanti-human
TRPV6(ECaC2,1:200;SantaCruzBiotechnology,Insight
Biotechnology, Wembley, UK), rabbit polyclonal anti-rat
calbindin-D9K (1:1000; SWANT, Bellizona, Switzerland),
rabbit polyclonal anti-human plasma membrane calcium
ATPase isoforms 1 (PMCA1) and 4 (PMCA4, 1:1000;
SWANT), goat polyclonal anti-human PTHrP (1:200;
Santa Cruz Biotechnology) and rabbit polyclonal
anti-human β-actin (1:1000; Abcam, Cambridge, UK).
Negative controls were prepared by omission of primary
antibody or pre-absorption with excess blocking peptide.
Immunoreactive species were detected with horseradish
peroxidase-conjugated secondary antibodies (1:2000,
Dako, Ely, UK) using an enhanced chemiluminescence
detection system (GE Healthcare). Immunoreactive
signal density was measured by densitometry (Bio-Rad
Molecular Analyst) and all signals fell within the linear
r a n g eo fd e t e c t i o n .
PTHrP immunohistochemistry
PTHrP immunohistochemistry was performed on
sections (5μm) of parafﬁn-embedded placentas using
standard techniques (Champion et al. 2004) after
antigen retrieval by immersing slides in 0.01m sodium
citrate buffer pH 6 and microwaving on full power for
10min.Non-speciﬁcbindingwasblockedwith10%rabbit
serum.GoatpolyclonalPTHrPantibody(2μgml −1;Santa
Cruz) or non-immune goat IgG as negative control
were applied overnight at 4◦C followed by incubation
with biotinylated rabbit anti-goat IgG (1:100 Dako Ltd,
UK) as secondary antibody. Sections were observed and
photographed using a Leitz Dialux 22 microscope (Leica
Microsystems, UK) and QICam 1394 digital camera
(QImaging, UK).
Statistical analysis
All data are presented as mean±s.e.m. where n
is the number of fetuses/placentas. ANOVA with
Bonferroni multiple comparison post hoc test was used
to test the differences between experimental groups.
Non-parametric comparisons were performed using
Mann–Whitney and Kruskal–Wallis tests. P<0.05 was
takenasthesigniﬁcancelevelunlessotherwisestated.
Abbreviations
PTHrP, parathyroid hormone-related protein; WT,
wild-type; HZ, heterozygous; NL, null; TRPV, trans-
ient receptor potential vanilloid subfamily of calcium
channels; ECaC, epithelial calcium channel; PMCA,
plasma membrane Ca2+-ATPase; dp, day of pregnancy;
PNS, postnuclear supernatant; IPYS, intraplacental yolk
sac; CaKmf, unidirectional maternofetal clearance of
calcium; CaKfp, unidirectional fetoplacental clearance of
calcium; CaKmf(intact), unidirectional maternofetal
clearance of calcium across intact (unperfused)
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Table 1. Fetal and placental weights, fetal : placental weight ratio and fetal plasma ionized Ca2+
concentration in WT (PTHrP+/+ ), HZ (PTHrP+/− ) and NL (PTHrP−/−) fetuses at 18 days of gestation
WT HZ NL
Fetal weight (g) 0.90 ± 0.01 (74) 0.89 ± 0.01 (131) 0.84 ± 0.02b (45)
Placental weight (g) 0.084 ± 0.001 (74) 0.087 ± 0.001 (131) 0.090 ± 0.002a (45)
Fetal : placental weight ratio 10.9 ± 0.2 (74) 10.3 ± 0.1 (131) 9.5 ± 0.2c,d (45)
Fetal plasma ionized Ca2+ (mM) 1.45 ± 0.02 (15) 1.45 ± 0.02 (25) 1.25 ± 0.07b,e (6)
Data presented as mean ± S.E.M.( n). aP < 0.05, bP < 0.01, cP < 0.001 versus WT; dP < 0.05, eP < 0.001 versus
HZ (ANOVA followed by Bonferroni’s multiple comparison test).
Table 2. Unidirectional maternofetal (CaKmf) and fetoplacental (CaKmf) clearance of 45Ca across the perfused
and intact placenta (CaKmf(intact))o fW T( PTHrP+/+), HZ (PTHrP+/−) and NL (PTHrP−/−) fetuses at 18 days of
gestation
WT HZ NL
CaKmf (μlm i n −1 (g placenta)−1) 86.4 ± 20.7∗ (3) 94.9 ± 10.1∗∗ (13) 172.0 ± 19.4 (7)
CaKfp (μlm i n −1 (g placenta)−1) 1.2 ± 0.3a (5) 3.4 ± 1.1b (4) 1.6 ± 0.9b (5)
CaKmf(intact) (μlm i n −1 (g placenta)−1) 128.5 ± 10.5 (42) 123.0 ± 7.6 (67) 158.1 ± 14.9† (28)
Data presented as mean ± S.E.M.( n). ∗P < 0.05, ∗∗P < 0.01 versus NL (ANOVA followed by Bonferroni’s multiple
comparison test). aP < 0.05, bP < 0.005 versus CaKmf (Mann–Whitney test). †P < 0.07 for difference between
groups (ANOVA).
placenta; CaJnet, net ﬂux of calcium to the fetus;
CaJmf, unidirectional maternofetal calcium ﬂux; CaJfm,
unidirectional fetomaternal calcium ﬂux.
Results
Fetal and placental weight and fetal ionized Ca2+
concentration
Placental and fetal weights, fetal:placental weight ratio
and fetal blood ionized Ca2+ concentration ([Ca2+]) for
WT, HZ and NL fetuses at 18dp are given in Table 1. Fetal
weightwaslower,andplacentalweighthigherinNLfetuses
compared to WT, with no difference with respect to other
group comparisons. In the NL group, this was reﬂected in
asigniﬁcantlyreducedfetal:placentalweightratiorelative
to HZ and WT groups.
[Ca2+] in NL fetuses was signiﬁcantly lower than WT
and HZ fetuses. There was a marked fetomaternal Ca2+
gradientapparentinbothWTandHZfetuseswith[Ca2+]
signiﬁcantly higher (P<0.001) than maternal [Ca2+]
(1.16±0.02mm,n= 69).However,inNLfetusestheCa2+
gradientwasabolishedasfetal[Ca2+]wasnotsigniﬁcantly
different to maternal [Ca2+].
Unidirectional clearances of 45Ca across perfused and
intact placenta
Table 2 gives unidirectional maternofetal clearance of
calcium (CaKmf) across the perfused placenta (taken as
the mean value of clearance over 25–45min, the period
over which CaKmf was shown to be in steady state for
all three genotypes; ANOVA, data not shown). CaKmf
was signiﬁcantly higher across the perfused placentas
of NL fetuses compared to their WT and HZ counter-
parts. Mirroring this, CaKmf across the intact placenta
(CaKmf(intact)) of NL fetuses was 23–29% higher compared
to WT and HZ groups (Table 2), the difference between
groups being marginally signiﬁcant (P<0.07). For all
genotypes CaKmf and CaKmf(intact) were not signiﬁcantly
different. There was no signiﬁcant difference between
groupsinunidirectionalfetoplacentalclearanceofcalcium
(CaKfp) (taken as the mean value of clearance over
10–45min, over which period values were at steady
state for all genotypes; ANOVA, data not shown). CaKfp
was<5% of CaKmf in all groups.
Fetal calcium accretion and CaJnet
Table 3 shows fetal calcium content for all genotypes at
17, 18 and 19dp normalized to ash weight. Ash weight,
unlikewetweight(Table1),wasnotsigniﬁcantlydifferent
between genotypes at each gestational age, in agreement
with previous observations (Kovacs et al. 2001). Fetal
calcium content was signiﬁcantly elevated in NL fetuses
at day 19 of pregnancy compared to WT and HZ fetuses,
but no difference was observed between genotypes at the
earlier gestational ages. The anticipated increase in fetal
calcium accretion with advancing gestation was observed
in all genotype groups between days 17–19 (P<0.0005,
ANOVAwithBonferroni’smultiplecomparisontest).The
calculatedmeanvaluefor CaJnet atday18iswithinthe95%
conﬁdencelimitsfor CaJmf measuredatthesamegestation
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Table 3. Fetal calcium content normalized to ash weight in WT (PTHrP+/+), HZ (PTHrP+/−) and NL (PTHrP−/−)
fetuses at 17, 18 and 19 days of gestation and estimates of CaJmf and CaJnet
WT HZ NL
Day 17 (mmol (g ash)−1) 2.23 ± 0.09 (6) 2.53 ± 0.04 (28) 2.46 ± 0.13 (9)
Day 18 (mmol (g ash)−1) 3.15 ± 0.13 (30) 3.17 ± 0.09 (64) 3.56 ± 0.19 (17)
Day 19 (mmol (g ash)−1) 3.45 ± 0.07∗∗ (29) 3.63 ± 0.08∗ (57) 4.12 ± 0.27 (18)
CaJmf† (nmol min−1 (g placenta)−1) 149 ± 12 143 ± 9 183 ± 17
CaJnet‡ (nmol min−1 (g placenta)−1)
Day 18 165 160 172
Day 19 234 236 315
Datapresentedasmean ± S.E.M.(n). ∗P < 0.05, ∗∗P < 0.01versusNLatday19(ANOVAfollowedbyBonferroni’s
multiple comparison test). † Values for CaJmf at day 18 calculated as:
CaJmf =Ca Kmf(intact)(fromTable2) × (maternal[Ca
2+]of 1.16mM))
‡ Values for CaJnet at day 18 and 19 calculated from mean calcium accretion over 24 h from days 17 to 18 and
18 to19, respectively, normalized to mean placental weight on day 18 or 19, respectively.
(Table 3). The rise in CaJnet between day 18 and day 19 in
NLfetuseswasapproximatelydoublethatforWTandHZ
fetuses.
PTHrP gene expression
PlacentalcDNAfromallthreegenotypesampliﬁedPTHrP
geneproduct(conﬁrmedbysequencing)althoughproduct
abundance appeared to be relatively lower in NL fetuses
Figure 1. PCR of paired placental cDNA (A) and fetal genomic
DNA (B)f r o mW T( PTHrP+/+), HZ (PTHrP+/−) and NL (PTHrP−/−)
fetuses of 3 individual litters using exon IV-speciﬁc primers, the
major exon encoding murine PTHrP
Lane B, H2O replacement of DNA. 100 base pair (bp) ladder is shown
on left. Ampliﬁcation product of the predicted size (138 bp) was visible
in placental cDNA from all three genotypes, whilst genomic DNA
demonstrated the predicted pattern of ampliﬁcation with no product
observable in NL fetuses.
(Fig.1A). However, no ampliﬁcation product was visible
in genomic DNA of NL fetuses (Fig.1B).
PTHrP immunohistochemistry
Figure2 provides conﬁrmation of the immunoreactive
speciﬁcity of the anti-human PTHrP antibody for murine
PTHrPandconﬁrmsnegligiblePTHrPproteinexpression
in the placentas of NL fetuses. In placentas from WT
and HZ fetuses, PTHrP immunoreactivity was intensely
localized to the intraplacental yolk sac (IPYS) as well
as being broadly distributed throughout the labyrinth
trophoblast.
Expression of calcium transport proteins
Probing placental protein for calcium transport
proteins that may mediate calcium epithelial inﬂux
(TRPV6/ECaC2; Fig.3A), cytosolic translocation
(calbindin-D9K;Fig.3B)andefﬂux(PMCA1andPMCA4;
Fig.3C and D) revealed immunoreactive signals of
appropriate size for all proteins. Signal intensity was
not signiﬁcantly different across genotype for TRPV6,
PMCA1 and PMCA4 (Fig.3E). However, in 7 of 9 litters
examined calbindin-D9K expression was higher in the
placentas of NL fetuses compared to their WT and HZ
littermates, as visible in Fig.3B, with a mean increase in
calbindin-D9K expression of ∼37% (Fig.3E; P<0.07,
Kruskal–Wallis test).
Discussion
In situ placental perfusion in the mouse (Bond et al.
2006a)hasgreatpotentialasamethodologyformeasuring
unidirectional clearances and ﬂuxes in a species in
which genetically modiﬁed strains are widely available. A
striking ﬁnding of this study (Table 3) is the concordance
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between transport measurements for an actively trans-
ported solute, calcium, obtained in three ways: across
fetal-side perfused placenta; across unperfused in situ
placenta in anaesthetized animals; and in vivo. These
observationsthereforeprovideconsiderableconﬁrmatory
conﬁdence in this methodology.
The values of CaKmf per unit placental weight obtained
here and our demonstration that calcium ﬂux across the
mouseplacentaishighlyasymmetric,with CaJmfprevailing
andapproaching CaJnet,accordwithpreviousobservations
in the rat (ˇ Stulc & ˇ Stulcov´ a, 1986; Mughal et al. 1989;
Robinson et al. 1989). Also, the very low ratio of CaKfm
to CaKmf is consistent with that found in the rat (ˇ Stulc &
ˇ Stulcov´ a, 1986) and, to a lesser degree, in women (ˇ Stulc
et al. 1994).
The phenotype of PTHrP-null mutants, a domed
skull, short snout and mandible with protruding tongue
Figure 2. Immunohistochemistry of PTHrP in
the placenta of mouse fetuses which were WT
(PTHrP+/+)( A), HZ (PTHrP+/−)( B)o rN L
(PTHrP−/−)( C) for PTHrP allele
Sections were incubated with goat anti-human
PTHrP antibody (2 μgm l −1; A–C) or goat IgG
(2 μgm l −1, D) as negative control. Intense staining
was observed within the IPYS (arrows) and
labyrinthine zone (L) of placentas of WT and HZ
fetuses. In contrast in the NL fetus, placental
staining was negligible and comparable to negative
control, conﬁrming a lack of placental PTHrP
protein expression in the null mutant. All scale bars
in A–D are 50 μm. E, Western blot of WT mouse
placental lysate (50 μg protein lane−1) probed with
either: +, afﬁnity puriﬁed goat anti-human PTHrP
antibody (1 : 200; 1 μgm l −1) alone giving a single
immunoreactive signal of predicted size; or −,i n
the presence of 5× excess (1 : 40) blocking peptide
which abolished signal.
and shortened limbs (Karaplis et al. 1994), were clearly
discernible at 18dp. In such mutants, PTHrP allele
expression was conﬁrmed to be absent using primers to
exonIV, the major exon encoding murine PTHrP. The
reduction of ∼6% in the weight of PTHrP-null fetuses
is consistent with previous observations (Kovacs et al.
2001)althoughothersreportasimilarbodyweightatbirth
(Karaplis et al. 1994). The efﬁciency of placental nutrient
transfer may be attenuated in NL fetuses as evidenced by
the reduced fetal:placental weight ratio.
In agreement with previous observations (Kovacs
et al. 1996; Tucci et al. 1996), PTHrP-null mutants
had a signiﬁcantly lower fetal blood ionized Ca2+
concentration resulting in abolition of the fetomaternal
Ca2+ concentration gradient. In contrast, fetal blood
ionized Ca2+ concentration in WT and HZ fetuses was
comparable and signiﬁcantly higher than maternal Ca2+
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concentration,alsodemonstratedpreviously(Kovacsetal.
1996; Tucci et al. 1996).
Previous studies have demonstrated a broad
distribution of PTHrP mRNA and immunoreactivity in
mouse placenta, being particularly abundant in the IPYS
which lines the sinus of Duval connecting the yolk sac
and the uterine lumen, but also detected in the labyrinth
trophoblast (Kovacs et al. 2001, 2002), as observed here.
As expected, PTHrP immunoreactivity was undetectable
in the placental labyrinth of NL fetuses consistent with
previous observations (Kovacs et al. 2001, 2002). We
infer that PTHrP gene transcription in the placenta of NL
fetuses (Fig. 1) arises from maternal cellular components
of decidua (Karperien et al. 1996) although decidual
PTHrP immunoreactivity in placenta from NL fetuses
was undetectable (data not shown), suggesting paracrine
effectsofmaternallyderivedPTHrPonplacentalfunction
can be discounted.
Our starting hypothesis was that CaJmf would be
down-regulated in placentas of NL fetuses based on
Figure 3. Western blots showing calcium transport
protein expression in the placentas of WT (PTHrP+/+),
HZ (PTHrP+/−)o rN L( PTHrP−/−) fetuses, matched from
two litters
A, TRPV6 (ECaC2; 20 μg membrane protein lane−1,3 0s
exposure); B, calbindin-D9K (20 μg PNS lane−1,1 5s
exposure); C, PMCA1 (30 μg membrane protein lane−1,
5 min exposure); and D, PMCA4 (60 μg membrane
protein lane−1, 5 min exposure). For all blots the
immunoreactive species detected accord with the predicted
molecular mass of the target protein, with signal abolished
by omission of primary antibody (not shown). E,
densitometric analysis (mean + S.E.M.) of immunoreactive
signal intensity for TRPV6 (ECaC2; n = 6), calbindin-D9K
(n = 9), PMCA1 (n = 6) and PMCA4 (n = 6) in placentas of
WT, HZ and NL fetuses. Mean calbindin-D9K expression in NL
fetuses was ∼37% higher than in WT and HZ littermates
(P < 0.07, Kuskal–Wallis). All signals fell within the linear
range of detection. For PMCA1 and PMCA4 signals
comprising the triplet and doublet species, respectively, were
analysed collectively. Equal protein loading was conﬁrmed by
densitometric analysis of replicate blots probed for β-actin
(data not shown).
previous evidence from PTHrP knockout mice (Kovacs
et al. 1996) and studies examining the acute effects of
PTHrP administration (outlined in the introduction).
However,incontrast,ourobservationsareallconsistentin
showing that calcium transport across the placenta of the
NLfetusis,infact,up-regulated.Thisassertionisbasedon
thefollowingevidence:(a) CaKmf wassigniﬁcantlyelevated
across the perfused placenta of the NL fetus compared
to WT and HZ littermates, and at a signiﬁcance level
of P<0.07 across the intact placenta (Table 2); (b) in
the NL group there was a signiﬁcant increase in fetal
calcium accretion by day 19 of gestation consistent with
an increased CaJnet (Table 3); (c) the very low and similar
values of CaKfp in all genotypes (Table 2) implies different
fetomaternal ﬂuxes beween genotypes cannot account
for (b); and (d) placental expression of calbindin-D9K,
a molecular marker of placental calcium ﬂux (Glazier
et al. 1992) that predicts fetal calcium content (Verhaeghe
et al. 1999), is probably raised (P<0.07) in NL fetuses
compared to WT and HZ littermates (Fig. 3).
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Ourpreviousﬂuxmeasurementsinthemouseimplicate
active calcium transport mechanisms (Bond et al.
2006a), compatible with our demonstration and that
of others (Kovacs et al. 2002) that calcium transport
proteinsmediatinginﬂux(TRPV6;ECaC2),transcytosolic
movement (calbindin-D9K) and efﬂux (PMCA) are
co-expressed in mouse placenta. Of these, expression of
calbindin-D9K appears, as noted previously (Kovacs et al.
2002), to be speciﬁcally altered by a lack of fetal PTHrP.
Theup-regulationincalbindin-D9Kexpressionparallels
the increase in CaKmf, as in the rat where placental
calbindin-D9K expression and CaKmf change in concert
(Glazier et al. 1992; Husain et al. 1994). The cellular
location of this altered calbindin-D9K expression remains
uncertain,asavarietyofcelltypesotherthanthelabyrinth
within the murine placenta express calbindin-D9K with
a predominant localization to the IPYS (Mathieu et al.
1989; Ogura et al. 1998; Verhaeghe et al. 1999; Kovacs
et al. 2002, 2005; Rummens et al. 2003). This distribution
of calbindin-D9K to the IPYS, along with a host of
other calcitropic hormones and receptors (Kovacs et al.
2002, 2005), has led to the proposal that the IPYS,
a unique structure restricted to rodent placentas and
formed by invagination of the primitive yolk sac into the
chorioallantoic placenta (Ogura et al. 1998), provides a
potential pathway for maternofetal calcium transfer in
addition to exchange across the labyrinth trophoblast
(Kovacs et al. 2002). However, the measurements of CaKmf
made here do not allow relative contribution of these
pathways to be addressed. Mutant mice lacking an IPYS
(Ogura et al. 1998) may be useful in examining this issue
further.
The collective evidence presented here supports the
notionthatmaternofetalcalciumtransportbytheplacenta
of NL fetuses is increased compared to WT and HZ
littermates. This contrasts with the conclusions of Kovacs
et al. (1996, 2001, 2002). They found diminished
placental calcium transport across the intact placenta,
normal fetal calcium content and reduced placental
calbindin-D9K expression. However, there were several
methodologicaldifferencesbetweenthetwostudieswhich
might contribute to this disparity including: (a) the
route, volume and amount of 45Ca tracer (intracardiac,
100μl, 50μCi 45Ca); (b) gestational age (17dp); (c)
anaesthetic(isoﬂuraneinhalation);and(d)incorporation
of 51Cr-EDTA (50μCi) as a paracellular marker with data
expressedas45Ca/51Crratio.Achangeinthe45Ca/51Crratio
as an index of calcium transport by Kovacs et al. (1996)
allows for the possibility that either the numerator or
denominatorisaltered.Relatedtothis,wehavepreviously
shown that the maternofetal clearance of 14C-mannitol
(ahydrophilictracerwithasimilardiffusioncoefﬁcientin
watertocalcium)issigniﬁcantlylowerintheNLrelativeto
its HZ and WT counterparts (Bond et al. 2006b), making
interpretation following normalization to a paracellular
markerunderthesecircumstancesapotentialmajorsource
of error.
The interrelationships between fetal calcium homeo-
stasis, placental calcium transport and fetal skeletal
mineralizationarecomplex,reliantupontheco-ordinated
action of PTHrP and PTH (Tobias & Cooper, 2004;
Miao et al. 2002). Fetal mice in which PTHrP or the
PTHR1 gene is ablated or which lack parathyroid glands
and so are unable to produce PTH (Hoxa3), all exhibit
fetal hypocalcaemia, but show disparate patterns with
regard to placental calcium transport, fetal PTH/PTHrP
plasma concentration or fetal calcium accretion (Kovacs
et al. 2001). This serves to emphasize that fetal calcaemia
reﬂects the composite dynamics of calcium ﬂux across
boththeplacentaandfetalbone,calciumexcretionbyfetal
kidney and its movement to and from amniotic ﬂuid. The
latter pathway is unlikely to confound the observations
presented here as amniotic ﬂuid calcium concentration is
unaltered in NL fetuses (Kovacs et al. 2001).
The critical role of PTHrP in fetal skeletal
morphogenesis is well established, acting in a paracrine
manner to stimulate the proliferation of chondrocytes
and delay their maturation (Karaplis et al. 1994; Miao
et al. 2002; Tobias & Cooper, 2004). Derangement of this
processbythetargeteddisruptionofthePTHrPgeneleads
to lethal dyschondroplasia, premature differentiation
of chondrocytes and advanced mineralization of the
endochondral skeleton. This skeletal dysmorphogenesis is
apparent as early as 14.5days of gestation (Karaplis et al.
1994), a time at which PTHrP/PTH receptor expression
is up-regulated in proliferating chondrocytes (MacLean
& Kronenberg, 2005). Our demonstration that a lack of
fetal PTHrP is associated with enhanced skeletal calcium
deposition is compatible with the excessive skeletal
mineralization and premature calciﬁcation/ossiﬁcation
found in NL fetuses (Karaplis et al. 1994) and agrees well
with the observations of Tucci et al. (1996). In contrast,
Kovacs et al. (2001) demonstrated comparable calcium
content between genotypes, perhaps surprising in view
of the excessive skeletal mineralization of NL fetuses.
This excessive skeletal mineralization of the PTHrP-null
mutant raises the possibility of an elevated fetal calcium
demand,whichwereasonstimulatesmaternofetalcalcium
transport by a mechanism independent of fetal PTHrP,
probablyinvolvingincreasedexpressionofcalbindin-D9K.
The regulatory stimuli involved in evoking this
calbindin-D9K response remain unclear. Fetal hypo-
calcaemia seems an unlikely candidate based on the
lack of correspondence between placental calbindin-D9K
expression which is reduced or unchanged in the face
of fetal hypocalcaemia (Kovacs et al. 2001, 2002). Other
studiesshowingthatexpressionofcalbindin-D9Kinrodent
placenta is not regulated by the biologically active form of
vitamin D, 1,25(OH)2D3 (Glazier et al. 1995; Rummens
et al. 2003; Kovacs et al. 2005) argue against its direct
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involvement.AsigniﬁcantelevationinfetalserumPTHin
bothPTHrP-andPTHR1-nullfetuses(Kovacsetal.2001)
is not associated with a consistent trend in calbindin-D9K
expression (Kovacs et al. 2002) suggesting a lack of direct
regulationbyPTH.AdditionallyPTH(1–84)hadnoeffect
on CaKmf acrosstheplacentaofintactratfetuses(Robinson
etal.1989).Multipleregulatoryfactorsmaybeinvolvedin
the trend to an altered placental calbindin-D9K expression
observed here.
In summary, this study provides clear evidence of
increased maternofetal calcium transport across the
placentaofPTHrP-nullfetuseswithincreasedfetalcalcium
accretion despite pronounced fetal hypocalcaemia and
abolition of the fetomaternal calcium gradient. The
asymmetric nature of this response is indicated by the
lack of effect on CaKfp. In situ placental perfusion of
the mouse placenta provides a valuable tool to examine
the regulation of unidirectional placental calcium ﬂux,
providing mechanistic insights regarding the role of fetal
PTHrP.
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